GS has just created a new IBD coverage group called "Cross Markets Group" in NY/London/Paris/Frankfurt which will focus on companies 2bn in value. From the description and the fact that the Head for Sponsors will lead the group, it seems that the focus will also be on PE portfolio companies and mid-market sponsors. Any opinions on this initiative? Will the experience be comparable to a traditional GS coverage group? In Europe at least, they would probably directly compete with RS which is often praised for the incredible deal exposure for juniors despite not being active on many large-cap deals.
Trending Content - Investment Banking Forum
| +171 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 29 | 18h |
| +163 | UBS Tech layoff | 52 | 2d |
| +149 | UBS’s M&A BANKERS ARE DOING TERRIBLY. $200M EXTRA IS BEING CUT | 31 | 1d |
| +121 | Leaked Interview Questions to Recruiting Services | 59 | 22m |
| +65 | How do YOU manage networking requests? | 20 | 14h |
| +60 | Are target prospects getting dumber? | 27 | 1d |
| +34 | MBB Pay Raises | 26 | 2d |
| +22 | US 2027 SA IB worried about background check | 8 | 58m |
| +21 | Earliest you can get fired | 7 | 12h |
| +20 | Career Crossroads | 4 | 42m |
Career Resources
I work in a classic group at GS and can say the Cross Markets Group is recruiting hard right now. The partners that are running it are legit and based on rumors I’ve heard about which MDs are moving over I would say it’s going to be a pretty good group. It’s also a major focus for the firm (“expanding the footprint”) so I’m sure the group will have a lot of resources to work with as they get up and running.